Medical information provided to AI is often incomplete
It is quite possible that in the near future, people will have to describe their symptoms to an AI before they can get a doctor’s appointment. The AI… read more.
It is quite possible that in the near future, people will have to describe their symptoms to an AI before they can get a doctor’s appointment. The AI… read more.
Johnson & Johnson announced that the FDA has approved a supplemental New Drug Application (sNDA) based on long-term data evaluating the safety and efficacy of Caplyta (lumateperone) for… read more.
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today’s artificial intelligence (AI) techniques now go far beyond mere automation: they make it possible… read more.
Medtronic has received CE mark for the Stealth AXiS surgical system, a next-generation platform that brings planning, navigation, and robotics together into one single, intelligent system. The Stealth… read more.
The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline… read more.
Viking Therapeutics announced that it will present two posters on its VK2735 program at the 33rd European Congress on Obesity (ECO) taking place in Istanbul, Türkiye on May 12-15,… read more.
Novartis announced that the European Commission (EC) approved Rhapsido (remibrutinib) for chronic spontaneous urticaria (CSU) in adult patients with inadequate response to H1-antihistamine treatment. Rhapsido is the first… read more.
AbbVie announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago. AbbVie will present 18… read more.
BridgeBio Pharma, Inc. presented long-term efficacy and safety data from the ATTRibute-CM open-label extension (OLE) trial, demonstrating sustained clinical benefit of acoramidis through Month 54 in patients with… read more.
A new scoping review from the University of Toronto reveals that caregivers of loved ones with ovarian cancer face significant emotional strain, heavy caregiving responsibilities, and limited support… read more.
Flinders University experts are warning that artificial intelligence (AI) must be carefully evaluated and governed before it is adopted widely in healthcare, saying rapid advances do not automatically… read more.
Alnylam Pharmaceuticals, Inc announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.